BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 7, 2000
View Archived Issues
Gene therapy results in neuroprotection, functional regeneration in primate PD model
Read More
Eukarion receives grant funds for SCS drug development
Read More
Recombinant human NGF safe but ineffective in diabetic polyneuropathy
Read More
HIV disease progression unaffected by the addition of HIV-1 immunogen to therapy
Read More
SynGenix and Glaxo Wellcome collaborate on novel pain therapies
Read More
Medicure licenses cardiovascular therapeutics from George Washington University
Read More
KS Biomedix and York Medical sign high-affinity antibody deal
Read More
Company Profile: Calyx
Read More
Seattle Genetics evaluates SGN-15/Taxotere combination in phase II
Read More
DIRECT trial begins for prevention and progression of retinopathy in diabetic patients
Read More
Hemosol receives go-ahead to begin phase I study of HML-115
Read More
Merger talks begin between two major Japanese pharmaceutical companies
Read More
U. of Michigan and Parke-Davis identify slow tight-binding inhibitor of KDO-8-P
Read More
SAR leading to APC-2059, a potent and selective human mast cell tryptase inhibitor
Read More
Pharmacokinetics, distribution and elimination of human CXC chemokine in mice
Read More
Novel, orally active iron chelator APO-363: preclinical pharmacokinetics reported at AAPS
Read More
RWJ-67657 advances to human studies: PK and cytokine inhibition determined in healthy subjects
Read More
Actinomycin D presented in Singapore as potential stroke-related incontinence therapy
Read More
153Sm-EDTMP: further beneficial effects in prostate cancer patients with bone lesions
Read More
AASLD news: optimal phase III anti-HBV dose of Coviracil selected from phase I/II data
Read More
CPMP recommends approval of Neurobloc for treatment of cervical dystonia
Read More
New 5-HT7 receptor antagonists designed at SB
Read More
SmithKline Beecham reveals new chemokine receptor antagonists and their potential use
Read More
Novel series from AHP with FSH-antagonist activity and utility as contraceptives
Read More
Synthesis and biological activity of 5-ht6 receptor antagonists reported by Canadian company
Read More
Heptazyme, an exciting new approach to chronic hepatitis C, covered at AASLD
Read More
New Gruenenthal compounds bind with high affinity to sodium and calcium channels
Read More
Temple researchers identify biologically active anticancer (Z)-styryl benzylsulfones
Read More
Recent AHP patent describes calcitonin inducers particularly useful for osteoporosis
Read More
Recent patent covers Bayer's newest agents for HBV
Read More
